AB 877 directs three California agencies to prepare and send one letter each to the chief financial officer of every health care service plan, health insurer, and Medi‑Cal managed care plan that covers substance use disorder (SUD) care in residential facilities. The letters must state that SUD treatment provided in licensed, certified, or unlicensed residential facilities is "almost exclusively nonmedical," explain how such services should be billed, and describe limited circumstances that would permit billing for medical treatment in those settings.
The requirement is procedural and temporary: the letters must be sent by October 1, 2026, and the statutory authority expires January 1, 2027. Although the bill does not create new coverage standards or penalties, the letters are intended to clarify billing expectations and, in practice, could change payer claim-handling, utilization review, and reimbursement for residential SUD programs.
At a Glance
What It Does
AB 877 mandates that the Department of Managed Health Care, the Department of Insurance, and the Department of Health Care Services each send a single digital or hardcopy letter to the CFO of every plan/insurer that covers SUD residential services in California. Each letter must assert that residential SUD care is primarily nonmedical, outline billing requirements for nonmedical services, and identify narrow exceptions when medical billing is appropriate.
Who It Affects
The directive targets CFOs at commercial health care service plans, health insurers, and Medi‑Cal managed care plans that provide in‑state coverage—particularly their claims, finance, and utilization review teams. It also has direct operational implications for residential SUD providers (licensed, certified, and unlicensed) and the State Department of Social Services, which the agencies must consult.
Why It Matters
The letters formalize an administrative position that could tighten payers' willingness to reimburse residential SUD providers for medical claims, reshape out‑of‑network adjudication, and prompt operational changes in billing, audits, and appeals—despite the absence of new statutory enforcement mechanisms.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
AB 877 does not change benefit law directly. Instead, it creates a short, targeted administrative instruction: three state agencies must each produce and send a one‑time letter to the finance chief of any plan that covers substance use disorder treatment in residential settings.
The text specifies the medium (digital or hardcopy), the intended recipient (chief financial officer), and the core content (a statement that residential SUD care is almost exclusively nonmedical, instructions to bill nonmedical services accordingly, and a discussion of limited circumstances allowing medical treatment billing).
The bill defines "residential facility" by listing four categories: family homes or group care facilities offering 24‑hour nonmedical care; alcohol or other drug programs certified under Chapter 7.1; AOD recovery or treatment facilities licensed under Chapter 7.5; and recovery residences as defined in Section 11833.05(f). That definition pulls together both licensed/certified clinical programs and peer‑based or unlicensed recovery homes into one umbrella for the purpose of the letters.Each of the three responsible agencies—DMHC, DOI, and DHCS—must consult with the State Department of Social Services when drafting their letters; the statute allows the agencies to consult with each other but assigns each agency the task of writing and sending the letter to its regulated entities.
The bill fixes the send date (October 1, 2026) in the text and makes the instruction temporary by repealing the sections on January 1, 2027.Although framed as informational guidance, the letters could influence day‑to‑day operations: CFOs and claims teams are the intended audience, so the communication aims at changing payer accounting, claims adjudication, and utilization review practices rather than altering licensing or clinical standards. The bill leaves the precise wording of "circumstances that allow for medical treatment" unspecified, which is likely to be the focal point of post‑letter disputes between payers, providers, and advocates.
The Five Things You Need to Know
AB 877 adds three temporary statutory sections: Health & Safety Code §1348.97, Insurance Code §10127.25, and Welfare & Institutions Code §14124.17.
Each designated agency must send exactly one digital or hardcopy letter to the chief financial officer of every covered plan or insurer; the recipient is explicitly the CFO, not clinical or compliance teams.
The letters must state that SUD treatment in licensed, certified, or unlicensed residential facilities is "almost exclusively nonmedical" and instruct plans on billing nonmedical services accordingly.
The statute defines "residential facility" by listing four categories—family/group homes for 24‑hour nonmedical care, certified AOD programs, licensed AOD treatment facilities, and recovery residences (per §11833.05(f)).
The letters must be sent on or before October 1, 2026, and each added section is repealed effective January 1, 2027.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
DMHC must notify health care service plans about billing for residential SUD care
This section directs the Department of Managed Health Care to prepare and send one letter to the CFO of each health care service plan that provides coverage for SUD in residential facilities. The mechanics matter: DMHC must consult with the State Department of Social Services and may consult with DOI and DHCS when drafting content, and it must choose whether to send a digital or hardcopy letter. The provision also contains the statutory definition of "residential facility" that governs DMHC's outreach and sets the October 1, 2026 send date and the January 1, 2027 repeal.
DOI must notify health insurers and describe billing expectations
The Department of Insurance gets a mirror requirement to notify health insurers. The section replicates the content elements (statement on nonmedical nature, billing instructions, and the limited medical exceptions) and requires DOI to consult with the State Department of Social Services while permitting consultation with DMHC and DHCS. Because DOI regulates different classes of carriers than DMHC, the statutory duplication ensures both plan types receive the same administrative message.
DHCS must notify Medi‑Cal managed care plans about SUD residential billing
The Department of Health Care Services must send the same form of letter to Medi‑Cal managed care plans that cover residential SUD services. This section again uses the shared definition of "residential facility" and requires consultation with the State Department of Social Services; it also authorizes DHCS to consult with DMHC and DOI. By addressing Medi‑Cal plans explicitly, the statute brings state‑administered Medicaid managed care into the administrative clarification.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Health plans and insurers (CFOs and finance teams): the letters give them an administratively endorsed rationale to treat most residential SUD claims as nonmedical, which can reduce exposure to contested medical‑claim payments and support consistent internal claims rules.
- State regulatory agencies (DMHC, DOI, DHCS, DSS): the consultation process and unified messaging let regulators align administrative expectations across licensing, oversight, and payer enforcement roles without changing licensing rules.
- Payer legal and utilization review teams: the formal letters provide documentation that payer counsel and reviewers can rely on when setting policy, defending denials, or updating claims systems.
Who Bears the Cost
- Residential SUD providers (licensed, certified, and unlicensed): providers risk increased denials of medical claims, revenue loss where services were previously paid as medical treatments, and higher administrative burden to reclassify charge lines or pursue appeals.
- Patients receiving residential SUD services: patients may face greater out‑of‑pocket costs or denials for services previously covered as medical, especially during transitions between clinical and peer‑support settings.
- State agencies and plan administrators: drafting, coordinating, sending, and responding to inquiries about the letters creates administrative work for regulators and for plan billing, finance, and compliance teams; handling downstream appeals and disputes will also consume resources.
Key Issues
The Core Tension
AB 877 pits payers' interest in clear, administrable billing rules and fiscal stewardship against providers' and patients' interest in access to medically necessary SUD services delivered in diverse residential settings; the bill offers administrative clarity without resolving the clinical, contractual, and legal line‑drawing that determines whether a given service is "medical" and therefore covered.
The statute creates an administrative communication, not new coverage law. That distinction matters because the letters themselves carry no enforcement mechanism, civil penalty, or change to licensing standards.
Payers could treat the letters as persuasive guidance or as a trigger to change adjudication policies, but courts and regulators will still resolve disputes under existing benefit contracts, state parity rules, and Medicaid requirements.
The bill leaves key terms and boundaries imprecise. It instructs agencies to identify "circumstances that allow for medical treatment" in residential settings but does not define those circumstances or set clinical thresholds—so disagreements about when a resident needs bona fide medical services (versus nonmedical support) are likely.
The broad statutory definition of "residential facility" groups licensed clinical programs with peer‑run and recovery residences, which may complicate claims handling because the clinical capacity and oversight differ across those settings. Finally, the temporary, single‑letter design raises implementation questions: a one‑time communication to CFOs may not reach or change the behavior of frontline claims processors, and there is no follow‑up, monitoring, or reporting requirement to measure impact.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.